Fungal infections in central venous catheters;Infección por hongos en catéteres venosos centrales

Revista Chilena de Pediatria

Volumn 73, Issue 5, 2002, Pages 489-494

  Pérez, Alejandra Y ^a   Contreras, Ana María S ^a,b   Zolezzi, Paola R ^a   Cruz, Carolina P ^b   Fierro, Carlos A ^a,b   Faúndez, Cecilia V ^a,b   Folatre, Isabel B ^a,b   Cea, Gustavo S ^b  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b Medical School   (Chile)

Author keywords

Candida; Hickman line

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FEVER; HUMAN; MALE; MYCOSIS; RETROSPECTIVE STUDY;

EID: 0036758452     PISSN: 03704106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tiraboschi IN, Bennett JE, Kauffman CA, et al: Deep Candida infections in the neutropenic and non-neutropenic host: An ISHAM symposium. Med Mycol 2000; 38: 199-204.
2. Pilecki O, Wysocki M, Swiatkiewicz V, et al: Fever in children with hematologic neoplastic diseases and implanted Broviac-Hickman catheters. Pediatr Pol 1995; 70: 213-8.
3. Landoy Z, Rotstein C, Lucey J, Fitzpatrick J: Hickman-Broviac catheter use in cancer patients. J Surg Oncol 1984; 26: 215-8.
4. Lowder JN, Lazarus HM, Herzig RH: Bacteremias and fungemias in oncologic patients with central venous catheters: Changing spectrum of infection. Arch Intern Med 1982; 142: 1456-9.
5. Rotstein C, Brock L, Roberts RS: The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995; 16: 451-8.
6. Tanabe N, Goto T, Inagaki J, Kimura K: Septicemia in patients with solid cancers in a Japanese cancer hospital-the significance of candidemia for cancer patients. Jpn J Clin Oncol 1991; 21: 52-8.
7. Lange BJ, Weiman M, Feuer EJ, et al: Impact of changes in catheter management on infectious complications among children with central venous catheters. Infect Control Hosp Epidemiol 1997; 18: 326-32.
8. Sitges-Serra A, Girvent M: Catheter-related bloodstream infections. World J Surg 1999; 23: 589-95.
9. Kullberg BJ, de Pauw BE: Therapy of invasive fungal infections. Neth J Med 1999; 55: 118-27.
10. Pearson ML and the Hospital Infection Control Practices Advisory Comite. Guideline for prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol 1996; 17: 438-73.
11. Body BA, Pfaller MA, Durrer J, et al: Comparison of the lysis centrifugation and radiometnc blood culture system for recovery of yeast. Eur J Clin Microbiol Infect Dis 1988; 7: 417-20.
12. Yagupsky P, Nolte FS, Menegus MA: Enhanced detection of Candida in blood cultures with BACTEC 460 system by use of the aerobic-hypertonic (8B) medium. Epidemiol Infect 1990; 105: 553-8.
13. Edwards JE: Candida species. En: Mandell, Douglas, Bennett. Principles and Practice of Infectious Disease. New York, Churchill Livingstone 1995; 2289-306.
14. Walsh TJ, Pizzo PA: Nosocomial fungal infections: A classification for hospital acquired fungal infections and mycoses arising from endogenous flora or reactivation. Am Rev Microbiol 1988; 42: 517-45.
15. Cobo P, Aguado JM, Lumbreras C, et al: Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients. Rev Clin Esp 1997; 197: 799-803.
16. Tchekmedyian NS, Newman K, Moody MR, et al: Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. Am J Med Sci 1986; 291: 419-24.
17. Otalzo OF, Brenner P: Informe de Vigilancia Epidemiológica de Infecciones Intrahospitalarias, MINSAL, Chile 1998.